Navigation Links
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Date:10/11/2011

most likely to benefit and increase the probability of success in the clinic.

"We know too much about the biology of cancer to continue to treat each patient without regard for the unique molecular characteristics of their individual tumor, leaving them vulnerable to disease recurrence," said Laura Shawver, Ph.D., Chief Executive Officer of Cleave Biosciences. "We foresee a future when the majority of cancer patients will be treated based on the molecular profile of their tumors, regardless of whether the cancer invades the lung, pancreas, liver or elsewhere. We believe this therapeutic approach ultimately stacks the odds in favor of the patient, the physician, as well as the payor."

Dr. Shawver has more than 25 years of experience in the development of small molecule drugs for cancer and other serious diseases. Prior to joining Cleave Biosciences, she spent the last year as an Entrepreneur in Residence at 5AM Ventures. Previously Dr. Shawver was CEO of Phenomix Corporation and President of SUGEN Inc. (acquired by Pharmacia), the company that uncovered key molecular pathways of cancer and developed the drugs Sutent™ and Palladia™.  Dr. Shawver was also employed at Berlex Biosciences, formerly known as Triton Biosciences.  She is the Founder of The Clearity Foundation, a not-for-profit organization dedicated to providing access to molecular profiling for ovarian cancer patients to optimize their treatment options.

Dr. Rolfe has over 20 years of industry experience in oncology drug discovery and development and is a recognized expert in the field of protein homeostasis. Before joining Cleave Biosciences, he spent a year at CytomX Therapeutics as Chief Scientific Officer and a year at Facet Biotech in the same role as well as interim Chief Medical Officer until its successful acquisition by Abbott Laboratories. Prior to joining Facet, Dr. Rolfe served as Vice President, Oncology Discovery at Millennium Pharmaceuticals where
'/>"/>

SOURCE Cleave Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amarillo Biosciences Teams with Animal Shelters to Improve Health and Enhance Immunity of Cats and Dogs
2. Genesis Biosciences Announces New Hire and Promotions on Operational and Scientific Staff
3. Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference
4. Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad
5. Avantra Biosciences Changes Company Name to Courtagen Life Sciences, Inc.
6. BD Biosciences Announces Winners of Research Grant Program
7. 3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer
8. Numira Biosciences Names New Board Member
9. Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
10. Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
11. BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... 14, 2014 Global Record Systems, ... information technology solutions for patients, physicians, the biopharmaceutical ... announced today the signing of a three-year Research ... Drug Administration (FDA). This initiative is designed ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
(Date:1/14/2014)... January 14, 2014 During the 1600’s through ... as “The Doctor’s Plague.” In this time period, doctors did ... led, at times, to the death of vulnerable patients. In ... know that they may be unwittingly transmitting herpes viruses to ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... , the leading meeting place for buyers and sellers ... Pharma Sourcing Conference to be held December 6-7, 2011 ... The two day program will be jointly hosted by ... issues that global chemical and pharmaceutical industry players are ...
... 26, 2011 Immune Design Corp. (IDC), a ... immunotherapies for infectious disease, cancer and allergy, announced ... research collaboration with Sanofi-Aventis to investigate the use ... toll–like receptor 4 (TLR-4) agonist, in the field ...
... RICHMOND, Calif., Oct. 25, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... results and accomplishments. For the third quarter ... of $9.6 million, or $0.18 per share, compared to a ... the same period in 2010. As of September 30, 2011, ...
Cached Biology Technology:Informex Introduces a Thorough Global Pharma Perspectives Conference 2Sangamo BioSciences Reports Third Quarter 2011 Financial Results 2Sangamo BioSciences Reports Third Quarter 2011 Financial Results 3Sangamo BioSciences Reports Third Quarter 2011 Financial Results 4Sangamo BioSciences Reports Third Quarter 2011 Financial Results 5Sangamo BioSciences Reports Third Quarter 2011 Financial Results 6
(Date:7/9/2014)... Sexual selection refers to species, selection for traits ... type of natural selection enhances opportunities to mate, the ... Biologists at the University of California, Riverside have now ... of a placenta are linked. Describing the life ... the family Poeciliidae, the researchers found that species with ...
(Date:7/9/2014)... July 9, 2014Biofuels derived from the oils produced by ... fuels. To achieve this goal, optimization of cost effective ... pond systems, is needed. Sapphire Energy has developed an ... pond algae cultivation systems, described in Industrial Biotechnology ... publishers. The article is available on the Industrial ...
(Date:7/9/2014)... Guelph scientist that involved fitting bumblebees with tiny ... neonicotinoid pesticide hampers bees, ability to forage for ... professor in Guelph,s School of Environmental Sciences, and ... July 9 in the British Ecological Society,s journal ... how long-term pesticide exposure affects individual bees, day-to-day ...
Breaking Biology News(10 mins):Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Controlling contamination in open algae ponds for biofuels 2Bee foraging chronically impaired by pesticide exposure: Study 2
... Assist with Solutions and Services to Support U.S. Army,s ... International Inc (NYSE: CAI ) announced today ... support the U.S. Army,s Biometrics Task Force. CACI received ... and Support Services - Unrestricted (BOSS-U) contract vehicle. The ...
... strategic farming practices might be part of the solution ... on 15 January in Current Biology , a ... reflect sunlight back out to space, summertime temperatures could ... much of central North America and mid-latitude Eurasia. That ...
... Mean Time / 13:00 Eastern Standard Time (TORONTO): Scientists ... have detected evidence that DNA may not be the ... called epigenetics may also account for some inherited traits ... of genetics and inheritance, and potentially provide a new ...
Cached Biology News:CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services 2CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services 3CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services 4Strategic farming practices could help mitigate global warming 2Rethinking the genetic theory of inheritance 2
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood CD8+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Biology Products: